C12Y 204/0201
Orotate phosphoribosyltransferase
Official title: Orotate phosphoribosyltransferase (2.4.2.10)
C12Y204/0201 (Orotate phosphoribosyltransferase) appears on 6 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 12
- Assignees
- 10
- Inventors
- 36
- Latest grant
- 21 Mar 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 3 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 2 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Gene-regulating compositions and methods for improved immunotherapy21 Mar 2023US 11,608,500 B2KSQ Therapeutics, Inc.
- Gene-regulating compositions and methods for improved immunotherapy23 Aug 2022US 11,421,228 B2KSQ Therapeutics, Inc.
- Gene-regulating compositions and methods for improved immunotherapy7 Sep 2021US 11,111,493 B2KSQ Therapeutics, Inc.
- Mortierella alpine uracil auxotroph with URA5 gene knocked out through homologous recombination, and construction method thereof29 May 2018US 9,982,269 B2Jiangnan University
- Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi25 Mar 2014US 8,680,252 B2Dyadic International (USA), Inc.
- Mutated lysophospholipase, and mutated aspergillus niger strain for expressing lysophospholipase11 Dec 2025US 2025/0376666 A1Wilmar (Shanghai) Biotechnology Research & Development Center Co., Ltd.
- Gene-regulating compositions and methods for improved immunotherapy13 Jul 2023US 2023/0220380 A1KSQ Therapeutics, Inc.
- Auxotrophic selection methods13 Oct 2022US 2022/0325301 A1Auxolytic Ltd
- Gene-regulating compositions and methods for improved immunotherapy6 Oct 2022US 2022/0315921 A1KSQ Therapeutics, Inc.
- Gene-regulating compositions and methods for improved immunotherapy16 Dec 2021US 2021/0388349 A1KSQ Therapeutics, Inc.
Most cited
By later US patents
- Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi10US 8,680,252 B2Dyadic International (USA), Inc. · 2014
- PyrF gene and the utilization thereof5US 7,001,751 B1Consortium fur Elektrochemische Industrie GmbH · 2006
- Gene-regulating compositions and methods for improved immunotherapy3US 11,111,493 B2KSQ Therapeutics, Inc. · 2021
- Gene-regulating compositions and methods for improved immunotherapy2US 11,421,228 B2KSQ Therapeutics, Inc. · 2022
- Gene-regulating compositions and methods for improved immunotherapy2US 11,608,500 B2KSQ Therapeutics, Inc. · 2023